Skip to main content
. 2017 Jan 30;1(1):1–12. doi: 10.1007/s41669-016-0009-9

Fig. 1.

Fig. 1

Flow of information through the different phases of the HIV vaccine cost-effectiveness model systematic review process. CEA cost-effectiveness analysis, DALY disability-adjusted life-year, QALY quality-adjusted life-year